Cite this DOI
10.46243/jst.2021.v06.i04.pp32-38 · Inhibition of Proliferation of K-562 Human Blood Cancer Cell Due To Opuntia Elatior Fruit Extract
APA (7th edition)
Narayankar, C. U., M. Mane, & R. Patil (2021). Inhibition of Proliferation of K-562 Human Blood Cancer Cell Due To Opuntia Elatior Fruit Extract. *Journal of Science & Technology*, *06*(04), 32–38. https://doi.org/10.46243/jst.2021.v06.i04.pp32-38
⬇ text Italics are shown as *asterisks* in plain text — the journal or book title and the volume.
BibTeX
@article{narayankar2021inhibition,
author = {Narayankar, Chirag U. and M. Mane and R. Patil},
title = {{Inhibition of Proliferation of K-562 Human Blood Cancer Cell Due To Opuntia Elatior Fruit Extract}},
journal = {Journal of Science \& Technology},
year = {2021},
month = {jul},
volume = {06},
number = {04},
pages = {32--38},
publisher = {Longman Publishers},
issn = {2456-5660},
doi = {10.46243/jst.2021.v06.i04.pp32-38},
url = {https://doi.org/10.46243/jst.2021.v06.i04.pp32-38},
language = {en},
abstract = {The ethanolic extract of Opuntia elatior was studied for anticancer potential against human blood cancer cell line K-562. The cytotoxicity of ethanolic extract was analyzed, using MTT assay and flow cytometric analysis. It was noticed that IC50 value of Opunria elatior curde extract was 74.32 µl/ml showing its cytotoxicity in the human blood cancer cell line by using MTT assay. The flow cytometry evaluation exhibits cell arrested in G2/M and S phases. Cell arrested due to Opuntia elatior extract shows higher than positive control Cisplatin. Thus Opuntia elatior fruit extract might be used as potent source of anticancerous compound against human blood cancer}
}RIS (EndNote, Zotero, Mendeley)
TY - JOUR TI - Inhibition of Proliferation of K-562 Human Blood Cancer Cell Due To Opuntia Elatior Fruit Extract AU - Narayankar, Chirag U. AU - M. Mane AU - R. Patil JO - Journal of Science & Technology PY - 2021 DA - 2021/07/14/ VL - 06 IS - 04 SP - 32 EP - 38 PB - Longman Publishers SN - 2456-5660 LA - en AB - The ethanolic extract of Opuntia elatior was studied for anticancer potential against human blood cancer cell line K-562. The cytotoxicity of ethanolic extract was analyzed, using MTT assay and flow cytometric analysis. It was noticed that IC50 value of Opunria elatior curde extract was 74.32 µl/ml showing its cytotoxicity in the human blood cancer cell line by using MTT assay. The flow cytometry evaluation exhibits cell arrested in G2/M and S phases. Cell arrested due to Opuntia elatior extract shows higher than positive control Cisplatin. Thus Opuntia elatior fruit extract might be used as potent source of anticancerous compound against human blood cancer DO - 10.46243/jst.2021.v06.i04.pp32-38 UR - https://doi.org/10.46243/jst.2021.v06.i04.pp32-38 ER -
CSL-JSON
{
"type": "article-journal",
"id": "10.46243/jst.2021.v06.i04.pp32-38",
"DOI": "10.46243/jst.2021.v06.i04.pp32-38",
"URL": "https://doi.org/10.46243/jst.2021.v06.i04.pp32-38",
"title": "Inhibition of Proliferation of K-562 Human Blood Cancer Cell Due To Opuntia Elatior Fruit Extract",
"source": "Smart Scholars DOI Registry",
"container-title": "Journal of Science & Technology",
"author": [
{
"family": "Narayankar",
"given": "Chirag U."
},
{
"family": "M. Mane"
},
{
"family": "R. Patil"
}
],
"issued": {
"date-parts": [
[
2021,
7,
14
]
]
},
"volume": "06",
"issue": "04",
"page": "32-38",
"publisher": "Longman Publishers",
"language": "en",
"abstract": "The ethanolic extract of Opuntia elatior was studied for anticancer potential against human blood cancer cell line K-562. The cytotoxicity of ethanolic extract was analyzed, using MTT assay and flow cytometric analysis. It was noticed that IC50 value of Opunria elatior curde extract was 74.32 µl/ml showing its cytotoxicity in the human blood cancer cell line by using MTT assay. The flow cytometry evaluation exhibits cell arrested in G2/M and S phases. Cell arrested due to Opuntia elatior extract shows higher than positive control Cisplatin. Thus Opuntia elatior fruit extract might be used as potent source of anticancerous compound against human blood cancer",
"ISSN": "2456-5660"
} ⬇ .json What citeproc and reference managers read; the DOI system hands it out for Accept: application/vnd.citationstyles.csl+json, and so does this registry's resolver.
From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2021.v06.i04.pp32-38 gives all four in one JSON answer.
